The microRNA-132/212 family fine-tunes multiple targets in Angiotensin II signalling in cardiac fibroblasts

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 4, 2015, Pages 1288-1297

  Eskildsen, Tilde V ^a   Schneider, Mikael ^b   Sandberg, Maria B ^b   Skov, Vibe ^b   Brønnum, Hasse ^a   Thomassen, Mads ^b   Kruse, Torben A ^b   Andersen, Ditte C ^a   Sheikh, Søren P ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angiotensin II; AT1R signalling; Cardiac fibroblasts; Fine tuning; MicroRNA; Targets

Indexed keywords

ANGIOTENSIN II; MESSENGER RNA; MICRORNA; MICRORNA 132; MICRORNA 212; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MIRN132 MICRORNA, RAT; MIRN212 MICRORNA, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SIZE; COMPUTER MODEL; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HEART FIBROBLAST; HORMONE ACTION; IN VITRO STUDY; MALE; MOLECULAR GENETICS; MULTIGENE FAMILY; NONHUMAN; RAT; RNA ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; METABOLISM; REPRODUCIBILITY; SOFTWARE; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; CELL SIZE; CELLS, CULTURED; FIBROBLASTS; MALE; MICRORNAS; MYOCARDIUM; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 84952944829     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314539367     Document Type: Article

References (37)

1. Mehta PK, Griendling KK,. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82-C97.
2. Sadoshima J, Izumo S,. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-23.
3. Camelliti P, Borg TK, Kohl P,. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005; 65: 40-51.
4. Jeppesen PL, Christensen GL, Schneider M, et al. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br J Pharmacol 2011; 164: 394-404.
5. Crowley SD, Gurley SB, Coffman TM,. AT(1) receptors and control of blood pressure: The kidney and more. Trends Cardiovasc Med 2007; 17: 30-34.
6. Bader M, Ganten D,. Update on tissue renin-angiotensin systems. J Mol Med (Berl) 2008; 86: 615-621.
7. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355.
8. Bartel DP,. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
9. Tognini P, Pizzorusso T,. MicroRNA212/132 family: Molecular transducer of neuronal function and plasticity. Int J Biochem Cell Biol 2012; 44: 6-10.
10. Vo N, Klein ME, Varlamova O, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Nat Acad Sci USA 2005; 102: 16426-16431.
11. Remenyi J, Hunter CJ, Cole C, et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010; 428: 281-291.
12. Eskildsen TV, Jeppesen PL, Schneider M, et al. Angiotensin II Regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci 2013; 14: 11190-11207.
13. Ucar A, Gupta SK, Fiedler J, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 2012; 3: 1078.
14. Villarreal FJ, Kim NN, Ungab GD, et al. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849-2861.
15. Dubey RK, Gillespie DG, Mi Z, et al. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: Role of A2B receptors. Circulation 1997; 96: 2656-2666.
16. Andersen DC, Andersen P, Schneider M, et al. Murine "cardiospheresa" are not a source of stem cells with cardiomyogenic potential. Stem Cells 2009; 27: 1571-1581.
17. Andersen DC, Jensen CH, Schneider M, et al. MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. Exp Cell Res 2010; 316: 1681-1691.
18. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
19. Hellemans J, Mortier G, De Paepe A, et al. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19.
20. Jin W, Reddy MA, Chen Z, et al. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem 2012; 287: 15672-15683.
21. Sahoo SK, Kim do H,. Characterization of calumenin in mouse heart. BMB Rep 2010; 43: 158-163.
22. Matteo RG, Moravec CS,. Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res 2000; 45: 961-970.
23. Yoshida K,. Role for DYRK family kinases on regulation of apoptosis. Biochem Pharmacol 2008; 76: 1389-1394.
24. Romero DG, Gomez-Sanchez EP, Gomez-Sanchez CE,. Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis. Physiol Genomics 2010; 42A: 259-266.
25. Tang WB, Ling GH, Sun L, et al. Smad anchor for receptor activation (SARA) in TGF-beta signaling. Front Biosci (Elite Ed) 2010; 2: 857-860.
26. Stevens MV, Broka DM, Parker P, et al. MEKK3 initiates transforming growth factor beta 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesis. Circ Res 2008; 103: 1430-1440.
27. Vermeulen K, Van Bockstaele DR, Berneman ZN,. The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36: 131-149.
28. Steinberg SF,. Cardiac actions of protein kinase C isoforms. Physiology (Bethesda) 2012; 27: 130-139.
29. Koyanagi T, Wong LY, Inagaki K, et al. Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats. Am J Physiology Heart Circ Physiol 2008; 295: H220-H226.
30. Yamazaki T, Yazaki Y,. Molecular basis of cardiac hypertrophy. Z Kardiol 2000; 89: 1-6.
31. Zhou J, Xu X, Liu JJ, et al. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Clin Exp Pharmacol Physiol 2007; 34: 1191-1198.
32. Batkai S, Thum T,. MicroRNAs in hypertension: Mechanisms and therapeutic targets. Curr Hypertens Rep 2012; 14: 79-87.
33. Nudelman AS, DiRocco DP, Lambert TJ, et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus. 2010; 20: 492-498.
34. Anand S, Majeti BK, Acevedo LM, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 2010; 16: 909-914.
35. Katare R, Riu F, Mitchell K, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011; 109: 894-906.
36. Liu N, Olson EN,. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18: 510-525.
37. Brenner JL, Jasiewicz KL, Fahley AF, et al. Loss of individual microRNAs causes mutant phenotypes in sensitized genetic backgrounds. in C. elegans. Curr Biology 2010; 20: 1321-1325.